APPLICATION
ANDA080874
TYPE
ANDA
ORIGINAL APPROVAL
1973-07-19
LATEST ACTION
1989-05-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
PIPERAZINE CITRATEDiscontinued
PIPERAZINE CITRATE EQ 250MG BASE · TABLET · ORAL
Approval history
1989-05-24Labeling · Supplement 4AP
1986-02-06Manufacturing (CMC) · Supplement 3AP
1973-07-19OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.